Evidence map›Paper›PMID 42383225›Full record

ArticleToxicology reports2026

Investigation into the oral toxicity profile of TruCBN™.

Mark R Bauter, Vaughn Hartung, Celeste Dunn, Robert Paul Jensen, Michael McCormick, Matthew Roberts, Denise DiCarlo-Emery

Abstract read
In one paragraph

Article in Toxicology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mark R BauterProduct Safety Labs, Dayton, NJ 08810, USA.
Vaughn HartungFloraworks, 9255 SE McBrod Ave., Milwaukie, OR 97222, USA.
Celeste DunnProduct Safety Labs, Dayton, NJ 08810, USA.
Robert Paul JensenFloraworks, 9255 SE McBrod Ave., Milwaukie, OR 97222, USA.
Michael McCormickFloraworks, 9255 SE McBrod Ave., Milwaukie, OR 97222, USA.
Matthew RobertsFloraworks, 9255 SE McBrod Ave., Milwaukie, OR 97222, USA.
Denise DiCarlo-EmeryProduct Safety Labs, Dayton, NJ 08810, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Floraworks TruCBN™ is a proprietary form of cannabinol (CBN), a high-purity CBN isolate processed to be substantially free of THC. CBN is derived from the Cannabis sativa plant, and is unique among cannabinoids, as it is not produced directly through the cannabis plant's metabolic processes; instead, it forms as an oxidative decomposition product of cannabidiol (CBD) and tetrahydrocannabinol (THC). CBN acts as a low affinity partial agonist at both CB

Indexed as

cannabinoidscannabinolmargin of safetyoral gavagesleepsubchronic toxicologyTruCBN™

Identifiers

PMID42383225
PMCPMC13315345

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.